Alpha Tau Medical Ltd
DRTS | NASDAQ
$15.30
-$0.20 (-1.29%)
Sep 22, 2026, 11:54 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 1.23M | 1.1M | 1.07M | 979K | 776K | 86K |
Gross Profit | -1.23M | -1.1M | -1.07M | -979K | -776K | -86K |
Operating Income | -42.29M | -36.04M | 35.68M | -32.14M | -13.79M | -9.24M |
Interest Income | 3.84M | 4.28M | 4.76M | 1.79M | 211K | 613K |
Pretax Income | -42.51M | -31.74M | -29.14M | -33.74M | -27.26M | -8.72M |
Net Income | -42.63M | -31.75M | -29.16M | -33.76M | -27.27M | -8.88M |
Selling & General & Admin | 10.22M | 7.92M | 9.26M | 11.25M | 2.34M | 1.7M |
Research & Development | 30.83M | 27.02M | 26.42M | 20.89M | 11.45M | 7.54M |
Other Expenses | n/a | n/a | -1.07M | n/a | n/a | n/a |
Operating Expenses | 41.06M | 34.94M | 34.61M | 32.14M | 13.79M | 9.24M |
Interest Expense | 419K | 344K | 39K | 1.77M | 13.27M | 217K |
Selling & Marketing Expenses | 1.86M | 1.25M | 1.92M | 974K | 482K | 288K |
Cost & Expenses | 42.29M | -36.04M | -35.68M | 32.14M | 13.79M | 9.24M |
Income Tax Expense | 121K | 6K | 16K | 20K | 7K | 158K |
Shares Outstanding (Basic) | 80.58M | 69.93M | 69.38M | 63.53M | 40.53M | 40.43M |
Shares Outstanding (Diluted) | 80.58M | 69.93M | 69.38M | 63.53M | 40.53M | 40.43M |
EPS (Basic) | -0.53 | -0.45 | -0.42 | -0.53 | -0.67 | -0.22 |
EPS (Diluted) | -0.53 | -0.45 | -0.42 | -0.53 | -0.67 | -0.22 |
EBITDA | -41.06M | -30.3M | -28.03M | -32.74M | -13.22M | -9.16M |
EBIT | -42.29M | -31.4M | -29.1M | -33.72M | -13.99M | -9.24M |
Depreciation & Amortization | 1.23M | 1.1M | 1.07M | 979K | 776K | 86K |
Add to Watchlist
Select watchlists to add or remove DRTS